Professor Jeffrey Idle

Academic biochemical pharmacologist and pharmacogeneticist. PhD St Mary’s Hospital Medical School (SMHMS) with Professor R. Tecwyn Williams, FRS. Co-discoverer in 1977 with Professor Robert L. Smith of the debrisoquine 4-hydroxylation polymorphism (CYP2D6). Wellcome Trust Senior Lecturer and Reader in Pharmacogenetics at SMHMS. Appointed at University of Newcastle in 1988 to first chair in pharmacogenetics. Head of Department of Pharmacological Sciences and Head of School of Clinical Medical Sciences at University of Newcastle. Appointed in 1995 Professor in Medicine and Molecular Biology at the Norwegian University of Science and Technology, subsequently Professor of Pharmacology, First Faculty of Medicine, Charles University Prague, then Visiting Professor at the University of Bern, Switzerland until 2016. Since 2002, contractor and consultant at the Laboratory of Metabolism (Chief, Frank J. Gonzalez, PhD), National Cancer Institute, NIH. Published over 300 articles in drug metabolism, pharmacogenetics and metabolomics.